ValiRx PLC (VALX.L)

VALX.L on London Stock Exchange

0.20GBp
5:41am EDT
Change (% chg)

0.00p (+0.00%)
Prev Close
0.20p
Open
0.20p
Day's High
--
Day's Low
--
Volume
15,805,787
Avg. Vol
--
52-wk High
--
52-wk Low
--

VALX.L

Chart for VALX.L

About

ValiRx plc is a United Kingdom-based biopharmaceutical company that develops technologies and products in oncology therapeutics and diagnostics. ValiRx focuses on treatment of cancer, specializing in epigenomic and genetic analysis. The Company’s technologies and products can also be applied to the other fields, such as... (more)

Overall

Beta: 0.77
Market Cap(Mil.): £7.54
Shares Outstanding(Mil.): 3,772.15
Dividend: --
Yield (%): --

Financials

  VALX.L Industry Sector
P/E (TTM): -- 160.23 41.71
EPS (TTM): -0.00 -- --
ROI: -108.29 -0.86 16.20
ROE: -105.47 -2.81 17.00
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Edison Investment Research
$10.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks